NCT06437158View on ClinicalTrials.gov

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Lymphatic Malformation
Interventions
DRUG

Bleomycin

To validated the efficacy and safety of different concentrations of Bleomycin in the sclerotherapy of lymphatic malformations for pediatric patients

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER